Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 947

The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.

Balancing repair and tolerance of DNA damage caused by alkylating agents

Open access
Fu, Dragony, Calvo, Jennifer A., Samson, Leona D. · 2012 · Nature Reviews Cancer

Abstract

Alkylating agents comprise a major class of frontline chemotherapeutic drugs that inflict cytotoxic DNA damage as their main mode of action, in addition to collateral mutagenic damage. Numerous cellular pathways, including direct DNA damage reversal, base excision repair (BER), and mismatch repair (MMR) respond to alkylation damage to defend against alkylation-induced cell death or mutation. However, maintaining a proper balance of activity both within and between these pathways is crucial for an organism's favorable response to alkylating agents. Furthermore, an individual's response to alkylating agents can vary considerably from tissue to tissue and from person to person, pointing to genetic and epigenetic mechanisms that modulate alkylating agent toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrc3185

Cites

185 of 185 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Kufe, D. W. et al. (eds) Cancer Medicine, 6th edn (BC Decker, Hamilton, Canada, 2003).
  2. Posnick, L. M. & Samson, L. D. Imbalanced base excision repair increases spontaneous mutation and alkylation sensitivity in Escherichia coli. J. Bacteriol. 181, 6763–6771 (1999). · doi:10.1128/jb.181.21.6763-6771.1999
  3. Calleja, F., Jansen, J. G., Vrieling, H., Laval, F. & van Zeeland, A. A. Modulation of the toxic and mutagenic effects induced by methyl methanesulfonate in Chinese hamster ovary cells by overexpression of the rat N-alkylpurine-DNA glycosylase. Mutat. Res. 425, 185–194 (1999). · doi:10.1016/s0027-5107(99)00034-2
  4. Freitas, S., Moore, D. H., Michael, H. & Kelley, M. R. Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer. Clin. Cancer Res. 9, 4689–4694 (2003).
  5. Kakolyris, S. et al. Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC). The J. Pathol. 189, 351–357 (1999). · DOI
  6. Liu, L. & Gerson, S. L. Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway. Curr. Opin. Investig. Drugs 5, 623–627 (2004).
  7. Hu, H. Y. et al. Identification of small molecule synthetic inhibitors of DNA polymerase β by NMR chemical shift mapping. J. Biol. Chem. 279, 39736–39744 (2004). · doi:10.1074/jbc.m402842200
  8. Kelley, M. R. DNA repair inhibitors: where do we go from here? DNA Repair 10, 1183–1185 (2011). · doi:10.1016/j.dnarep.2011.09.003
  9. Allay, E., Veigl, M. & Gerson, S. L. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea. Oncogene 18, 3783–3787 (1999). · doi:10.1038/sj.onc.1202697
  10. Qin, X., Zhou, H., Liu, L. & Gerson, S. L. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis. Carcinogenesis 20, 1667–1673 (1999). · doi:10.1093/carcin/20.9.1667
  11. Reese, J. S., Qin, X., Ballas, C. B., Sekiguchi, M. & Gerson, S. L. MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure. J. Hematother. Stem Cell Res. 10, 115–123 (2001). · doi:10.1089/152581601750098354
  12. Hongeng, S. et al. O6-Methylguanine-DNA methyltransferase protein levels in pediatric brain tumors. Clin. Cancer Res. 3, 2459–2463 (1997).
  13. Bobola, M. S. et al. O6-methylguanine-DNA methyltransferase in pediatric primary brain tumors. Clin. Cancer Res. 7, 613–619 (2001).
  14. Weingart, J. et al. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. J. Clin. Oncol. 25, 399–404 (2007). · doi:10.1200/jco.2006.06.6290
  15. Moritz, T., Mackay, W., Glassner, B. J., Williams, D. A. & Samson, L. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res. 55, 2608–2614 (1995).
  16. Maze, R. et al. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. Proc. Natl Acad. Sci. USA 93, 206–210 (1996). References 137 and 138 show that transplantation of bone marrow cells overexpressing MGMT can suppress alkylating agent myelosuppression and toxicity in mice. · doi:10.1073/pnas.93.1.206
  17. Jelinek, J. et al. Long-term protection of hematopoiesis against the cytotoxic effects of multiple doses of nitrosourea by retrovirus-mediated expression of human O6-alkylguanine-DNA-alkyltransferase. Blood 87, 1957–1961 (1996). · doi:10.1182/blood.v87.5.1957.1957
  18. Allay, J. A., Koç, O. N., Davis, B. M. & Gerson, S. L. Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors. Clin. Cancer Res. 2, 1353–1359 (1996).
  19. Neff, T. et al. Methylguanine methyltransferase–mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model. J. Clin. Invest. 112, 1581–1588 (2003). · doi:10.1172/jci200318782
  20. Maze, R., Hanenberg, H. & Williams, D. A. Establishing chemoresistance in hematopoietic progenitor cells. Mol. Med. Today 3, 350–358 (1997). · doi:10.1016/s1357-4310(97)01094-0
  21. Jansen, M. et al. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMTP140K into hematopoietic stem cells. Cancer Gene Ther. 9, 737–746 (2002). · doi:10.1038/sj.cgt.7700490
  22. Lips, J. & Kaina, B. Repair of O6-methylguanine is not affected by thymine base pairing and the presence of MMR proteins. DNA Repair 487, 59–66 (2001). · doi:10.1016/s0921-8777(01)00105-7
  23. Rasmussen, L. J. & Samson, L. The Escherichia coli MutS DNA mismatch binding protein specifically binds O6-methylguanine DNA lesions. Carcinogenesis 17, 2085–2088 (1996). References 156 and 158 provide a direct link between the MMR pathway and alkylation damage by showing that MUTS and MUTSα can directly recognize O6meG lesions. · doi:10.1093/carcin/17.9.2085
  24. Kaina, B. The interrelationship between SCE induction, cell survival, mutagenesis, aberration formation and DNA synthesis inhibition in V79 cells treated with N-methyl-N-nitrosourea or N-methyl-N'-nitro-N-nitrosoguanidine. Mutat. Res. 142, 49–54 (1985). · doi:10.1016/s0165-7992(85)80012-9
  25. Sansom, O. J. & Clarke, A. R. The ability to engage enterocyte apoptosis does not predict long-term crypt survival in p53 and Msh2 deficient mice. Oncogene 21, 5934–5939 (2002). · doi:10.1038/sj.onc.1205760
  26. Sansom, O. J. et al. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. DNA Repair 2, 1029–1039 (2003). · doi:10.1016/s1568-7864(03)00111-3
  27. Bugni, J. M., Meira, L. B. & Samson, L. D. Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins. Oncogene 28, 734–741 (2009). · DOI

Cited by

See all 947

Metadata

Authors
Fu, D., Calvo, J. A., & Samson, L. D.
Venue
Nature Reviews Cancer
Published
2012-01-12
Volume
12
Issue
2
Pages
104-120
ISSN
  • 1474-175X
  • 1474-1768
OpenAlex
W2094144162
Cited by
947
References
185
FWCI
21.03
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.